J&J starts two-dose trial of its COVID-19 vaccine candidate – Reuters

LONDON (Reuters) – Johnson & Johnson launched a new large-scale late-stage trial on Monday to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benef… [read more]

Leave a Comment